Abstract:Abstract Ewing sarcoma (ES), a malignancy of bone and soft tissue that affects children and young adults, is characterized by early metastasis to lung and bone and by oncogenic ews/ets translocations. We previously observed the histone methyltransferase Enhancer of Zeste, Drosophila, Homolog 2 (EZH2) to be regulated by EWS-FLI1 and highly increased in ES. We hypothesized non-coding RNAs to contribute to epigenetic processes and malignancy of ES. Here we show by ChIP on chip analysis that EZH2 occupies promoter regions of putative tumor suppressor miRNAs, oncogenic miRNAs and differentiation-associated miRNAs in ES and investigated their functional relevance by miRNA mimic, RNA interference, and functional assays. We show that hsa-miR-203a-3p (miR-203), a promoter of epidermal differentiation and trigger to exit cell cycle, was found epigenetic silenced in ES. We not only observed miR-203 up-regulation in different ES lines after EZH2 knock down or treatment with the EZH2 inhibitors GSK126 but also after histone de-acetylase inhibition (HDACi) via Trichostatin A (TSA) as well as MS-275. Similarly, treatment of ES lines with the DNA-methylation inhibitor 5′-azacytidine resulted in a strong up-regulation of miR-203 in ES. On the other hand, de-regulated expression of miR-203 after transient transfection with a miR-203-mimic identified a feed back loop resulting in a down-regulation of EWS-FLI1 and EZH2 in ES cell lines as compared to controls. In functional assays we observed that an increased expression of miR-203 suppressed contact dependent as well as independent growth in ES. In addition, in vitro invasiveness was strongly impaired after over-expression of miR-203. Taken together, we demonstrate the essential need for epigenetic suppression of miR-203 expression in ES that otherwise would suppress critical features of ES malignancy such as contact independent growth and invasiveness of ES. These results further provide a rationale for epigenetic combination therapy directed to reverse miR-203 suppression. Citation Format: Tim Hensel, Esther Heid, Stephanie Plehm, Stefan Burdach, Günther H. Richter. Epigenetic suppression of miRNA-203 promotes Ewing sarcoma malignancy. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 492. doi:10.1158/1538-7445.AM2015-492

MiR-107 suppresses cell proliferation and tube formation of Ewing sarcoma cells partly by targeting HIF-1β

The Effects of Mirnas-107 on Cell Proliferation, Senescence and Invasion of Pancreatic Cancer PANC-1 Cells

Mir-106B Promotes Cell Invasion and Metastasis Via PTEN Mediated EMT in ESCC.

The miR-146b-5p promotes Ewing’s sarcoma cells progression via suppressing the expression of BTG2

MiR-107 inhibits the malignant biological behavior of esophageal squamous cell carcinoma by targeting TPM3

MicroRNA-107 Inhibits Proliferation of Prostate Cancer Cells by Targeting Cyclin E1.

MicroRNA-133a Inhibits Osteosarcoma Cells Proliferation and Invasion Via Targeting IGF-1R

miR-107 Targets NSG1 to Regulate Hypopharyngeal Squamous Cell Carcinoma Progression through ERK Pathway

LINC00662 Promotes Melanoma Progression by Competitively Binding Mir-107 and Activating the Β-Catenin Signaling Pathway.

MicroRNA-140-5p Targets Insulin Like Growth Factor 2 Mrna Binding Protein 1 (IGF2BP1) to Suppress Cervical Cancer Growth and Metastasis.

miR-204-5p regulates cell proliferation, invasion, and apoptosis by targeting IL-11 in esophageal squamous cell carcinoma

Circulating Exosomal MiR-107 Restrains Tumorigenesis in Diffuse Large B-Cell Lymphoma by Targeting 14-3-3η

Abstract 492: Epigenetic suppression of miRNA-203 promotes Ewing sarcoma malignancy

miR‑107 promotes the erythroid differentiation of leukemia cells via the downregulation of Cacna2d1.

Bone marrow mesenchymal stem cell-derived exosomal LINC00847 inhibits the proliferation, migration, and invasion of Ewing sarcoma

Bone marrow mesenchymal stem cells-derived exosomal microRNA-19b-3p targets SOCS1 to facilitate progression of esophageal cancer

MiR-195-5p Reduces Esophageal Cancer Cell Proliferation Through The IGF-1R/AKT Axis

MiR-205 Inhibits the Invasion and Migration of Esophageal Squamous Cell Carcinoma by Modulating SMAD1 Expression

Let-7a suppresses Ewing sarcoma CSCs’ malignant phenotype via forming a positive feedback circuit with STAT3 and lin28

MiR-92a-2-5p suppresses esophageal squamous cell carcinoma cell proliferation and invasion by targeting PRDX2

MicroRNA-375 suppresses esophageal cancer cell growth and invasion by repressing metadherin expression